Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	acetylcholine-gated monoatomic cation-selective channel activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.84e-08	17	111	5	GO:0022848
GeneOntologyMolecularFunction	acetylcholine receptor activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	1.51e-07	23	111	5	GO:0015464
GeneOntologyMolecularFunction	acetylcholine binding	CHRNA5 CHRNB1 CHRNB2 CHRNB3	6.22e-07	13	111	4	GO:0042166
GeneOntologyMolecularFunction	excitatory extracellular ligand-gated monoatomic ion channel activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.94e-06	43	111	5	GO:0005231
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	1.61e-05	57	111	5	GO:1904315
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.08e-05	60	111	5	GO:0099529
GeneOntologyMolecularFunction	transmitter-gated channel activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.07e-05	65	111	5	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.07e-05	65	111	5	GO:0022824
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	6.14e-05	75	111	5	GO:0098960
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	6.97e-05	77	111	5	GO:0005230
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF136 ZBTB20 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 NFIC ZNF565 ZNF433 NOTCH2 ZNF572	2.18e-04	1271	111	18	GO:0000987
GeneOntologyMolecularFunction	neurotransmitter receptor activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.40e-04	100	111	5	GO:0030594
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF699 ZNF883 ZNF850 ZKSCAN5 ZNF774 HIVEP3 ZNF594 NFIC ZNF398 ZNF565 ZBTB18 ZNF433 NOTCH2 ZNF572	2.74e-04	1412	111	19	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 NFIC ZNF398 ZNF565 ZNF433 ZNF572	4.13e-04	1459	111	19	GO:0000977
GeneOntologyMolecularFunction	peptidyltransferase activity	GGT2P GGT1	4.53e-04	6	111	2	GO:0000048
GeneOntologyMolecularFunction	leukotriene-C(4) hydrolase	GGT2P GGT1	4.53e-04	6	111	2	GO:0002951
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF136 ZBTB20 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 NFIC ZNF565 ZNF433 ZNF572	5.00e-04	1244	111	17	GO:0000978
GeneOntologyMolecularFunction	leukotriene C4 gamma-glutamyl transferase activity	GGT2P GGT1	8.39e-04	8	111	2	GO:0103068
GeneOntologyMolecularFunction	glutathione hydrolase activity	GGT2P GGT1	1.07e-03	9	111	2	GO:0036374
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	1.11e-03	140	111	5	GO:0099094
GeneOntologyMolecularFunction	monoatomic cation channel activity	PKDREJ CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3 CACNA2D4	3.07e-03	343	111	7	GO:0005261
GeneOntologyMolecularFunction	omega peptidase activity	GGT2P GGT1	3.49e-03	16	111	2	GO:0008242
GeneOntologyBiologicalProcess	acetylcholine receptor signaling pathway	SORBS1 CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.81e-07	51	109	6	GO:0095500
GeneOntologyBiologicalProcess	cellular response to acetylcholine	SORBS1 CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.56e-07	53	109	6	GO:1905145
GeneOntologyBiologicalProcess	response to acetylcholine	SORBS1 CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	4.97e-07	56	109	6	GO:1905144
GeneOntologyBiologicalProcess	postsynaptic signal transduction	SORBS1 CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	1.73e-06	69	109	6	GO:0098926
GeneOntologyBiologicalProcess	synaptic transmission, cholinergic	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.46e-06	44	109	5	GO:0007271
GeneOntologyBiologicalProcess	response to nicotine	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	1.38e-05	58	109	5	GO:0035094
GeneOntologyBiologicalProcess	behavioral response to nicotine	CHRNA5 CHRNB1 CHRNB2	2.30e-05	11	109	3	GO:0035095
GeneOntologyBiologicalProcess	excitatory postsynaptic potential	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3 NLGN2	6.65e-05	130	109	6	GO:0060079
GeneOntologyBiologicalProcess	chemical synaptic transmission, postsynaptic	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3 NLGN2	1.31e-04	147	109	6	GO:0099565
GeneOntologyCellularComponent	acetylcholine-gated channel complex	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.42e-08	18	113	5	GO:0005892
GeneOntologyCellularComponent	dopaminergic synapse	CHRNA5 CHRNB2 CHRNB3 NLGN2	5.49e-06	22	113	4	GO:0098691
GeneOntologyCellularComponent	postsynaptic membrane	CLSTN2 CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3 EFNB2 LZTS1 NLGN2	3.56e-04	405	113	9	GO:0045211
Domain	ZINC_FINGER_C2H2_2	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF804B ZNF398 ZNF565 ZNF839 ZBTB18 ZNF433 ZNF572	8.49e-10	775	111	22	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF804B ZNF398 ZNF565 ZNF839 ZBTB18 ZNF433 ZNF572	8.90e-10	777	111	22	PS00028
Domain	Znf_C2H2-like	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF804B ZNF398 ZNF565 ZNF839 ZBTB18 ZNF433 ZNF572	1.39e-09	796	111	22	IPR015880
Domain	Znf_C2H2	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF804B ZNF398 ZNF565 ZNF839 ZBTB18 ZNF433 ZNF572	1.72e-09	805	111	22	IPR007087
Domain	ZnF_C2H2	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF804B ZNF398 ZNF565 ZNF839 ZBTB18 ZNF433 ZNF572	1.84e-09	808	111	22	SM00355
Domain	zf-C2H2	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF398 ZNF565 ZBTB18 ZNF433 ZNF572	4.19e-09	693	111	20	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF398 ZNF565 ZBTB18 ZNF433 ZNF572	4.30e-09	694	111	20	IPR013087
Domain	-	ZNF136 ZBTB20 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF398 ZNF565 ZBTB18 ZNF433 ZNF572	1.77e-08	679	111	19	3.30.160.60
Domain	Nicotinic_acetylcholine_rcpt	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.81e-08	16	111	5	IPR002394
Domain	-	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.09e-07	23	111	5	1.20.120.370
Domain	Acetylcholine_rcpt_TM	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	2.09e-07	23	111	5	IPR027361
Domain	Neurotransmitter_ion_chnl_CS	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	6.85e-06	45	111	5	IPR018000
Domain	Neur_chan_memb	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	7.64e-06	46	111	5	PF02932
Domain	Neur_chan_LBD	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.51e-06	47	111	5	PF02931
Domain	NEUROTR_ION_CHANNEL	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.51e-06	47	111	5	PS00236
Domain	Neurotrans-gated_channel_TM	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.51e-06	47	111	5	IPR006029
Domain	-	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.51e-06	47	111	5	2.70.170.10
Domain	Neur_channel	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.51e-06	47	111	5	IPR006201
Domain	Neur_chan_lig-bd	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.51e-06	47	111	5	IPR006202
Domain	KRAB	ZNF136 ZNF177 ZNF212 ZNF699 ZNF850 ZKSCAN5 ZNF774 ZNF398 ZNF565 ZNF433	5.47e-05	358	111	10	PS50805
Domain	KRAB	ZNF136 ZNF177 ZNF212 ZNF699 ZNF850 ZKSCAN5 ZNF398 ZNF565 ZNF433	2.87e-04	358	111	9	PF01352
Domain	KRAB	ZNF136 ZNF177 ZNF212 ZNF699 ZNF850 ZKSCAN5 ZNF398 ZNF565 ZNF433	3.58e-04	369	111	9	SM00349
Domain	KRAB	ZNF136 ZNF177 ZNF212 ZNF699 ZNF850 ZKSCAN5 ZNF398 ZNF565 ZNF433	3.65e-04	370	111	9	IPR001909
Domain	DUF3669_Znf	ZNF212 ZNF398	5.17e-04	6	111	2	IPR022137
Domain	DUF3669	ZNF212 ZNF398	5.17e-04	6	111	2	PF12417
Domain	zf-C2H2_6	ZNF136 ZNF212 ZNF699 ZNF883 ZNF850 ZKSCAN5 ZNF433 ZNF572	5.76e-04	314	111	8	PF13912
Domain	Znf_SWIM	ZSWIM5 ZSWIM6	1.23e-03	9	111	2	IPR007527
Domain	ZF_SWIM	ZSWIM5 ZSWIM6	1.23e-03	9	111	2	PS50966
Domain	DUF4599	SPATA31D4 SPATA31D3	2.22e-03	12	111	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	2.22e-03	12	111	2	IPR027970
Domain	-	F8 EFNB2	3.04e-03	14	111	2	2.60.40.420
Domain	CADHERIN_1	PCDHB5 PCDHB4 CLSTN2 FAT1	4.63e-03	113	111	4	PS00232
Domain	Cadherin	PCDHB5 PCDHB4 CLSTN2 FAT1	4.63e-03	113	111	4	PF00028
Domain	CADHERIN_2	PCDHB5 PCDHB4 CLSTN2 FAT1	4.78e-03	114	111	4	PS50268
Domain	-	PCDHB5 PCDHB4 CLSTN2 FAT1	4.78e-03	114	111	4	2.60.40.60
Domain	CA	PCDHB5 PCDHB4 CLSTN2 FAT1	4.93e-03	115	111	4	SM00112
Domain	Cadherin-like	PCDHB5 PCDHB4 CLSTN2 FAT1	5.08e-03	116	111	4	IPR015919
Domain	Cadherin	PCDHB5 PCDHB4 CLSTN2 FAT1	5.40e-03	118	111	4	IPR002126
Domain	Cupredoxin	F8 EFNB2	7.48e-03	22	111	2	IPR008972
Domain	ADAM_spacer1	ADAMTS6 ADAMTS20	8.16e-03	23	111	2	IPR010294
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	6.89e-08	9	70	4	M27597
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	6.89e-08	9	70	4	MM15313
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	1.79e-07	11	70	4	M883
Pathway	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	2.68e-07	12	70	4	M48008
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	2.68e-07	12	70	4	MM15312
Pathway	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	5.37e-07	14	70	4	M757
Pathway	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	CHRNA2 CHRNA5 CHRNB2 CHRNB3	7.30e-07	15	70	4	MM14704
Pubmed	Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence.	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	8.24e-11	10	113	5	20736995
Pubmed	Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse.	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	9.69e-10	15	113	5	8838678
Pubmed	Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes.	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	1.41e-09	16	113	5	19259974
Pubmed	Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans.	CHRNA2 CHRNA5 CHRNB2 CHRNB3	3.67e-09	7	113	4	1505988
Pubmed	No evidence for association between 19 cholinergic genes and bipolar disorder.	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	3.71e-09	19	113	5	17373692
Pubmed	Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function.	CHRNA2 CHRNA5 CHRNB2 CHRNB3	7.32e-09	8	113	4	17559419
Pubmed	Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.	CHRNA2 CHRNA5 CHRNB2 CHRNB3	1.31e-08	9	113	4	8906617
Pubmed	Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.	CHRNA2 CHRNA5 CHRNB2 CHRNB3	1.31e-08	9	113	4	19228980
Pubmed	Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults.	CHRNA2 CHRNA5 CHRNB3	3.34e-08	3	113	3	23943838
Pubmed	Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus.	CHRNA2 CHRNA5 CHRNB2 CHRNB3	3.43e-08	11	113	4	12225896
Pubmed	Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans.	CHRNA2 CHRNA5 CHRNB1 CHRNB3	5.13e-08	12	113	4	20584212
Pubmed	Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.	CHRNA2 CHRNA5 CHRNB2 CHRNB3	1.03e-07	14	113	4	19059502
Pubmed	Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.	CHRNA5 CHRNB2 CHRNB3	1.33e-07	4	113	3	27645992
Pubmed	Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence.	CHRNA5 CHRNB2 CHRNB3	1.33e-07	4	113	3	19482438
Pubmed	CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.	CHRNA5 CHRNB2 CHRNB3	1.33e-07	4	113	3	20854418
Pubmed	Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses.	CHRNA2 CHRNA5 CHRNB3	3.32e-07	5	113	3	9193799
Pubmed	Nicotinic acetylcholine receptors: from structure to brain function.	CHRNA2 CHRNA5 CHRNB3	3.32e-07	5	113	3	12783266
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	BCLAF1 GOLM2 MAZ PCDHB5 ZNF362 DCLRE1B SMC5 ZNF850 PTGFRN REPIN1 JMJD1C ZNF691 PIGT UTP4 NOTCH2 RNF111 SYMPK	3.60e-07	1203	113	17	29180619
Pubmed	Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task.	CHRNA5 CHRNB2 CHRNB3	6.63e-07	6	113	3	15922075
Pubmed	Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32.	CHRNA5 CHRNB2 CHRNB3	1.16e-06	7	113	3	9009220
Pubmed	Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions.	CHRNA2 CHRNB2 CHRNB3	1.16e-06	7	113	3	20231857
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	SORBS1 ZMIZ1 TAOK2 RESF1 KATNIP TANGO6	4.42e-06	130	113	6	12421765
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZBTB20 GOLM2 ZNF362 ZSWIM6 ZMIZ1 AHDC1 JMJD1C HIVEP3 PTPRB EFNB2 CLK2 NFIC EEPD1 KATNIP NLGN2 ZNF839 NOTCH2	6.43e-06	1489	113	17	28611215
Pubmed	Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.	ZBTB20 CLSTN2 EFNB2 NOTCH2 CDON	7.40e-06	82	113	5	31073041
Pubmed	Gamma glutamyl transferase activity is independently associated with oxidative stress rather than SYNTAX score.	GGT2P GGT1	1.05e-05	2	113	2	25180444
Pubmed	Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits.	CHRNA5 CHRNB2	1.05e-05	2	113	2	8663494
Pubmed	Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging.	CHRNA5 CHRNB2	1.05e-05	2	113	2	15788760
Pubmed	Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of α5 or β2 subunits.	CHRNA5 CHRNB2	1.05e-05	2	113	2	22072695
Pubmed	Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia.	CHRNA5 CHRNB1	1.05e-05	2	113	2	22406075
Pubmed	ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.	ZNF774 NOTCH2	1.05e-05	2	113	2	31659254
Pubmed	Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study.	GGT2P GGT1	1.05e-05	2	113	2	25280803
Pubmed	Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.	CHRNA2 CHRNA5	1.05e-05	2	113	2	19279237
Pubmed	Binding to gating transduction in nicotinic receptors: Cys-loop energetically couples to pre-M1 and M2-M3 regions.	CHRNB1 CHRNB2	1.05e-05	2	113	2	19279256
Pubmed	Clinical application value of hepatitis B virus basal core promoter 1762/1764 and GGTII and GGT in patients with HBV-DNA-positive primary liver cancer.	GGT2P GGT1	1.05e-05	2	113	2	37904480
Pubmed	Human GGT2 does not autocleave into a functional enzyme: A cautionary tale for interpretation of microarray data on redox signaling.	GGT2P GGT1	1.05e-05	2	113	2	23682772
Pubmed	CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.	CHRNB1 CHRNB2	1.05e-05	2	113	2	11104662
Pubmed	[Mutational analysis of CHRNB2 and CHRNA2 genes in southern Chinese population with autosomal dominant nocturnal frontal lobe epilepsy].	CHRNA2 CHRNB2	1.05e-05	2	113	2	21287502
Pubmed	Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation.	CHRNA5 CHRNB2	1.05e-05	2	113	2	17401441
Pubmed	Genome wide expression profiling of the mesodiencephalic region identifies novel factors involved in early and late dopaminergic development.	CHRNA5 CHRNB2 CHRNB3	1.18e-05	14	113	3	23213462
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SLC37A3 SZT2 RTTN REPIN1 AHDC1 TAOK2 HIVEP3 FAT1 ZNF398 ZFYVE26 NLGN2 ZNF839 NOTCH2 SYMPK	1.45e-05	1105	113	14	35748872
Pubmed	Identification of candidate genes at the corticoseptal boundary during development.	ZBTB20 ACIN1 NOTCH2	1.48e-05	15	113	3	16458080
Pubmed	Rapid isolation and characterization of 118 novel C2H2-type zinc finger cDNAs expressed in human brain.	ZNF212 ZBTB18	3.13e-05	3	113	2	7633419
Pubmed	Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity.	HIPK1 CLK2	3.13e-05	3	113	2	28289210
Pubmed	Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes.	CHRNA5 CHRNB2	3.13e-05	3	113	2	19139153
Pubmed	A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy.	CHRNA2 CHRNB2	3.13e-05	3	113	2	19058950
Pubmed	Identification of pharmacogenetic markers in smoking cessation therapy.	CHRNA2 CHRNA5	3.13e-05	3	113	2	18165968
Pubmed	Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.	CHRNB2 CHRNB3	3.13e-05	3	113	2	20923852
Pubmed	Identification of four classes of brain nicotinic receptors using beta2 mutant mice.	CHRNB1 CHRNB2	3.13e-05	3	113	2	9614223
Pubmed	Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population.	CHRNA2 CHRNB2	3.13e-05	3	113	2	18991851
Pubmed	The role of the nAChR subunits α5, β2, and β4 on synaptic transmission in the mouse superior cervical ganglion.	CHRNA5 CHRNB2	3.13e-05	3	113	2	30891952
Pubmed	Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function.	CHRNA5 CHRNB2	3.13e-05	3	113	2	20881005
Pubmed	Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.	CHRNA5 CHRNB2	3.13e-05	3	113	2	24647947
Pubmed	Efficient expression of functional (α6β2)2β3 AChRs in Xenopus oocytes from free subunits using slightly modified α6 subunits.	CHRNB2 CHRNB3	3.13e-05	3	113	2	25068303
Pubmed	Binding of HIV-1 gp120 to the nicotinic receptor.	CHRNB1 CHRNB2	3.13e-05	3	113	2	1397297
Pubmed	Hidden function of neuronal nicotinic acetylcholine receptor beta2 subunits in ganglionic transmission: comparison to alpha5 and beta4 subunits.	CHRNA5 CHRNB2	3.13e-05	3	113	2	15694199
Pubmed	Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney.	GGT2P GGT1	3.13e-05	3	113	2	2573352
Pubmed	Probing the non-canonical interface for agonist interaction with an α5 containing nicotinic acetylcholine receptor.	CHRNA5 CHRNB2	3.13e-05	3	113	2	24144909
Pubmed	CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients.	CHRNA2 CHRNB2	3.13e-05	3	113	2	18226955
Pubmed	Characterization of the murine Ephrin-B2 promoter.	MAZ EFNB2	3.13e-05	3	113	2	19268698
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TUBGCP5 PTGFRN ZKSCAN5 JMJD1C HIVEP3 EEPD1 UTP4 NLGN2 TANGO6	3.48e-05	493	113	9	15368895
Pubmed	Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.	DBH CHRNA2 CHRNA5 CHRNB2 CHRNB3	4.33e-05	118	113	5	19156168
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	DBH CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3 NLGN2	5.86e-05	300	113	7	19086053
Pubmed	A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70.	MCM2 ACIN1	6.25e-05	4	113	2	19058849
Pubmed	Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.	CHRNA5 CHRNB2	6.25e-05	4	113	2	19481067
Pubmed	Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.	CHRNA5 CHRNB2	6.25e-05	4	113	2	18184829
Pubmed	Examination of the nicotine dependence (NICSNP) consortium findings in the Iowa adoption studies population.	CHRNA2 CHRNB1	6.25e-05	4	113	2	19307444
Pubmed	Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.	ZBTB20 EFNB2	6.25e-05	4	113	2	21113149
Pubmed	Subunit composition of α5-containing nicotinic receptors in the rodent habenula.	CHRNA5 CHRNB2	6.25e-05	4	113	2	22380605
Pubmed	Ceramides modulate cell-surface acetylcholine receptor levels.	CHRNA2 CHRNB1	6.25e-05	4	113	2	18023270
Pubmed	Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum.	CHRNA5 CHRNB3	6.25e-05	4	113	2	22396410
Pubmed	Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.	CHRNA5 CHRNB3	6.25e-05	4	113	2	20840187
Pubmed	Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.	CHRNA5 CHRNB3	6.25e-05	4	113	2	17135278
Pubmed	Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes.	CHRNB2 CHRNB3	6.25e-05	4	113	2	16314871
Pubmed	Transcription factor GATA-3 regulates the transcriptional activity of dopamine beta-hydroxylase by interacting with Sp1 and AP4.	DBH REPIN1	6.25e-05	4	113	2	18338249
Pubmed	Lung lining fluid glutathione attenuates IL-13-induced asthma.	GGT2P GGT1	1.04e-04	5	113	2	18063838
Pubmed	Gamma-glutamyltranspeptidase knockout mice as a model for understanding the consequences of diminished glutathione on T cell-dependent immune responses.	GGT2P GGT1	1.04e-04	5	113	2	10940879
Pubmed	Cataract development in gamma-glutamyl transpeptidase-deficient mice.	GGT2P GGT1	1.04e-04	5	113	2	11095909
Pubmed	Expression of gamma-glutamyl transpeptidase in midgestation mouse yolk sac and mouse visceral yolk sac carcinoma cells.	GGT2P GGT1	1.04e-04	5	113	2	7641802
Pubmed	Phenotypic characterization of Ggt1(dwg/dwg) mice,a mouse model for hereditary γ-glutamyltransferase deficiency.	GGT2P GGT1	1.04e-04	5	113	2	23615310
Pubmed	Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes.	CHRNA5 CHRNB2	1.04e-04	5	113	2	20377613
Pubmed	The mouse skin carcinogenesis model.	GGT2P GGT1	1.04e-04	5	113	2	9627710
Pubmed	Gamma-glutamyl transpeptidase and its role in melanogenesis: redox reactions and regulation of tyrosinase.	GGT2P GGT1	1.04e-04	5	113	2	12453183
Pubmed	gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function.	GGT2P GGT1	1.04e-04	5	113	2	11003618
Pubmed	Gamma-glutamyl transpeptidase gene organization and expression: a comparative analysis in rat, mouse, pig and human species.	GGT2P GGT1	1.04e-04	5	113	2	10392451
Pubmed	Immunocytochemical localization of gamma-glutamyltranspeptidase during fetal development of mouse kidney.	GGT2P GGT1	1.04e-04	5	113	2	2891746
Pubmed	Hyperoxia-induced lung injury in gamma-glutamyl transferase deficiency is associated with alterations in nitrosative and nitrative stress.	GGT2P GGT1	1.04e-04	5	113	2	19850887
Pubmed	Differential expression and function of nicotinic acetylcholine receptors in subdivisions of medial habenula.	CHRNB2 CHRNB3	1.04e-04	5	113	2	25031416
Pubmed	Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice.	GGT2P GGT1	1.04e-04	5	113	2	12810527
Pubmed	Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice.	GGT2P GGT1	1.04e-04	5	113	2	8755578
Pubmed	Reproductive defects in gamma-glutamyl transpeptidase-deficient mice.	GGT2P GGT1	1.04e-04	5	113	2	11089562
Pubmed	Liver-Specific Overexpression of Gamma-Glutamyltransferase Ameliorates Insulin Sensitivity of Male C57BL/6 Mice.	GGT2P GGT1	1.04e-04	5	113	2	28660214
Pubmed	Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.	GGT2P GGT1	1.04e-04	5	113	2	12468440
Pubmed	N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice.	GGT2P GGT1	1.04e-04	5	113	2	26977590
Pubmed	Low ethanol concentration alters CHRNA5 RNA levels during early human development.	CHRNA5 CHRNB2	1.04e-04	5	113	2	20438829
Pubmed	Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia.	GGT2P GGT1	1.04e-04	5	113	2	12225953
Pubmed	Identification of a sixth promoter that directs the transcription of gamma-glutamyl transpeptidase type III RNA in mouse.	GGT2P GGT1	1.04e-04	5	113	2	7775425
Pubmed	Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene.	GGT2P GGT1	1.04e-04	5	113	2	8566783
Pubmed	Therapeutic Effect of GGsTop, Selective Gamma-glutamyl Transpeptidase Inhibitor, on a Mouse Model of 5-Fluorouracil-induced Oral Mucositis.	GGT2P GGT1	1.04e-04	5	113	2	30591459
Pubmed	Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility.	GGT2P GGT1	1.04e-04	5	113	2	9139708
Pubmed	Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue.	GGT2P GGT1	1.04e-04	5	113	2	20622017
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF136 ZBTB20 ZNF177 ZNF212 MAZ ZNF362 ZNF699 ZNF883 ZNF850 REPIN1 ZKSCAN5 ZNF774 ZNF691 HIVEP3 ZNF594 ZNF398 ZNF565 ZBTB18 ZNF433 ZNF572	9.85e-12	718	76	20	28
GeneFamily	Cholinergic receptors nicotinic subunits	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	4.84e-09	16	76	5	173
GeneFamily	Zinc fingers SWIM-type\|Mitogen-activated protein kinase kinase kinases	ZSWIM5 ZSWIM6	6.16e-04	9	76	2	90
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT2P GGT1	1.32e-03	13	76	2	564
GeneFamily	Cadherin related	CLSTN2 FAT1	2.28e-03	17	76	2	24
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS6 ADAMTS20	2.85e-03	19	76	2	50
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	SORBS1 F8 PTPRB EFNB2 ADAMTS6 HYAL2	6.90e-06	181	113	6	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SORBS1 PTPRB EFNB2 ZBTB18 HYAL2 TANGO6	6.90e-06	181	113	6	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ZBTB20 BCLAF1 HIPK1 ARFGEF1 JMJD1C DDHD1	8.57e-06	188	113	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SORBS1 F8 PTPRB EFNB2 ADAMTS6 HYAL2	9.10e-06	190	113	6	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SORBS1 F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.02e-05	194	113	6	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	facs-Heart-RA-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS1 TAOK2 PTPRB EFNB2 EEPD1 HYAL2	1.06e-05	195	113	6	30c75761079fa1e1a3b84d23c88a222f459d5ce5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SORBS1 F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.09e-05	196	113	6	d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SORBS1 F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.12e-05	197	113	6	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SORBS1 PTPRB EFNB2 ADAMTS6 EEPD1 HYAL2	1.15e-05	198	113	6	a1ccbf0e653b2dd665c2254920eb9b37243cc0bd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 HIVEP3 PTPRB EFNB2 ADAMTS6 HYAL2	1.15e-05	198	113	6	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	SORBS1 F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.18e-05	199	113	6	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	GOLM2 DHX33 GLCCI1 FAT1 NOTCH2 CDON	1.18e-05	199	113	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Sigmoid-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	DCLRE1B ZMIZ1 ZNF594 JRK ZFYVE26 PARPBP	1.22e-05	200	113	6	4e489ecf472857357d45e9f6c7a812aa48b72ebf
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TRIM39 ZSWIM6 EFNB2 ZNF839 FCMR	5.50e-05	160	113	5	8aaf6ac4f33ea291387fdbf9ff1a91d559391774
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	SZT2 HIPK1 SORBS1 ZNF362 NOTCH2	5.84e-05	162	113	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	ADAMTS6 BEND7 NOTCH2 CDON	5.95e-05	83	113	4	7893ce9fbf34c6250dca9c265fe9b2d4cb889ade
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCLRE1B F8 TAOK2 PTPRB HYAL2	6.55e-05	166	113	5	9d4b44eb56ad38c26aed73444edf389abca6bdf6
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D231\|Adult / Lineage, Cell type, age group and donor	F8 PTPRB EFNB2 ADAMTS6 C13orf42	6.93e-05	168	113	5	aca34c51758c65925ad24110294a72b2dea6db72
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB EFNB2 HMCN2 ADAMTS6 HYAL2	7.13e-05	169	113	5	c7fc3a8c44f07c557b60d469717b66e2f5863d38
ToppCell	367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF850 PTPRB ADAMTS6 ZNF565 PARPBP	7.54e-05	171	113	5	e3cab55f39879e2bd3e8bda91802181075839bc4
ToppCell	367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF850 PTPRB ADAMTS6 ZNF565 PARPBP	7.54e-05	171	113	5	52fdc2a4ec36fb91583b1215362548ceb6740ae1
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F8 PTPRB EFNB2 ADAMTS6 HYAL2	8.18e-05	174	113	5	18ab52d8bbca0507fee220e0c4fc765fc47dda34
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRB PARPBP HYAL2 TANGO6 SYMPK	8.18e-05	174	113	5	6c36d607c48267a75ab4da6fb2fe3f931d1b3b52
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SCFD2 PCDHB4 SORBS1 SMC5 ZNF594	8.40e-05	175	113	5	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA3 PCDHB4 F8 NRK HYAL2	8.63e-05	176	113	5	5d3b2395bb842eea39175f5af6a4c76527e2fc31
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TUBGCP5 F8 PTPRB EFNB2 TNR	8.87e-05	177	113	5	16197068260fc062bf8b730a51a199887ea580b9
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|tumor_Lung / Location, Cell class and cell subclass	ZSWIM5 F8 PTPRB EFNB2 HYAL2	8.87e-05	177	113	5	f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCell	COVID-19-kidney-Stressed_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 JMJD1C CHRNA5 PTPRB EFNB2	9.35e-05	179	113	5	754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 F8 JMJD1C PTPRB EFNB2	9.60e-05	180	113	5	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ZNF699 ADAMTS6 ZBTB18 ZNF433 FCMR	1.01e-04	182	113	5	ab78df9de3878a6d67106a40094c893601de8076
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.04e-04	183	113	5	ce8be9418b473ea94ec806edc7a2078cc30c1703
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SORBS1 F8 PTPRB ADAMTS6 HYAL2	1.15e-04	187	113	5	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SZT2 CCNJ GLCCI1 PTPRB EFNB2	1.15e-04	187	113	5	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SCFD2 ZBTB20 ZSWIM5 ELP1 ADAMTS6	1.15e-04	187	113	5	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	SORBS1 PTPRB EFNB2 TNR HYAL2	1.15e-04	187	113	5	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SZT2 CCNJ GLCCI1 PTPRB EFNB2	1.15e-04	187	113	5	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	SORBS1 PTPRB EFNB2 ADAMTS6 HYAL2	1.18e-04	188	113	5	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PCDHB5 PTGFRN FRMD1 FAT1 NRK	1.18e-04	188	113	5	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	Control-Endothelial_cells\|Control / group, cell type (main and fine annotations)	SORBS1 PTPRB EFNB2 TNR HYAL2	1.18e-04	188	113	5	3953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.21e-04	189	113	5	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DHX33 CCNJ CHRNA5 ZNF691 HYAL2	1.21e-04	189	113	5	0739baad9a7da511dd3d7249f84299aee88370a1
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.21e-04	189	113	5	16e019fd6e2376110b767739754389891f391669
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.24e-04	190	113	5	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	SORBS1 F8 PTPRB EFNB2 ADAMTS6	1.24e-04	190	113	5	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	SORBS1 FAT1 PTPRB ADAMTS6 EEPD1	1.24e-04	190	113	5	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SORBS1 PTPRB EFNB2 ADAMTS6 EEPD1	1.24e-04	190	113	5	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.27e-04	191	113	5	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLCCI1 DMXL1 HIVEP3 ZBTB18 FCMR	1.30e-04	192	113	5	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.30e-04	192	113	5	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.30e-04	192	113	5	dfa6adc776621f4b51d731b796c0421855b2297c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLCCI1 DMXL1 HIVEP3 ZBTB18 FCMR	1.30e-04	192	113	5	ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.30e-04	192	113	5	517bc24b9ad5e2b5a3609ca55d7327c4700db9db
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	SORBS1 PTPRB EFNB2 ADAMTS6 HYAL2	1.33e-04	193	113	5	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	IPF-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	SORBS1 PTPRB EFNB2 ADAMTS6 HYAL2	1.33e-04	193	113	5	d7750a7575ef257963b7f1c64fa67c52dbff797b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB EFNB2 HMCN2 ADAMTS6 HYAL2	1.33e-04	193	113	5	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.33e-04	193	113	5	ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SORBS1 PTPRB EFNB2 ADAMTS6 HYAL2	1.33e-04	193	113	5	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.33e-04	193	113	5	7401e276b644b254c692160d0e7417ec28d50aa4
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB EFNB2 ADAMTS6 EEPD1 HYAL2	1.36e-04	194	113	5	a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell	droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.36e-04	194	113	5	1ac52b00ea0b0ddbd04f5d85fa8c086980a78926
ToppCell	IPF-Endothelial-VE_Capillary_B\|IPF / Disease state, Lineage and Cell class	SORBS1 PTPRB EFNB2 ADAMTS6 HYAL2	1.36e-04	194	113	5	169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.36e-04	194	113	5	f6c9cc362ccdbc7e790f7c8d1c56cab3557c5306
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SORBS1 PTPRB ADAMTS6 EEPD1 HYAL2	1.36e-04	194	113	5	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB EFNB2 HMCN2 ADAMTS6 HYAL2	1.40e-04	195	113	5	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLCCI1 DMXL1 HIVEP3 ZBTB18 FCMR	1.40e-04	195	113	5	d77423d0ec64b397c6d1eec181c5fc0acaa92d63
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.40e-04	195	113	5	52b2bbf12e5f86c493f6634697aeb23a68cc916d
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.40e-04	195	113	5	e5f14f6015ea5e6fa065f906ad22157e3de15c68
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.40e-04	195	113	5	5b84fd5be31386eb1d6048bbf28626032361842e
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLCCI1 DMXL1 HIVEP3 ZBTB18 FCMR	1.40e-04	195	113	5	f5bf4797972185afa76638293166abd536e5472f
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SORBS1 F8 PTPRB EFNB2 HYAL2	1.40e-04	195	113	5	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	facs-Lung-ENDOMUCIN-18m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.43e-04	196	113	5	f6df26ab9eebae893768a4f70a064ce9f60da93c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB EFNB2 HMCN2 ADAMTS6 HYAL2	1.43e-04	196	113	5	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.43e-04	196	113	5	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.43e-04	196	113	5	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZBTB20 MCM2 GLCCI1 NLGN2 TNR	1.43e-04	196	113	5	8faac7fbdee3a9297023c3151ef1751605413e44
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	F8 PTPRB EFNB2 EEPD1 HYAL2	1.43e-04	196	113	5	915e4a7422058be246b54760df31e8a607310625
ToppCell	facs-Lung-ENDOMUCIN\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLM2 SORBS1 PTPRB EFNB2 HYAL2	1.43e-04	196	113	5	69f03546c42c942ab8ac8746167c8d44d574b4c6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	F8 HIVEP3 PTPRB EFNB2 ADAMTS6	1.43e-04	196	113	5	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 F8 PTPRB EFNB2 ADAMTS6	1.43e-04	196	113	5	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	SORBS1 F8 PTPRB EFNB2 ADAMTS6	1.46e-04	197	113	5	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SORBS1 F8 PTPRB EFNB2 HYAL2	1.46e-04	197	113	5	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HIVEP3 PTPRB EFNB2 ADAMTS6 HYAL2	1.50e-04	198	113	5	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 HIVEP3 PTPRB EFNB2 HYAL2	1.50e-04	198	113	5	1378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.50e-04	198	113	5	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 HIVEP3 PTPRB EFNB2 HYAL2	1.50e-04	198	113	5	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRB EFNB2 ADAMTS6 EEPD1 HYAL2	1.50e-04	198	113	5	f7aa809040fa9f5782b92eec1f289d690eb5c7bd
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SORBS1 F8 PTPRB EFNB2 EEPD1	1.50e-04	198	113	5	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.50e-04	198	113	5	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ZBTB20 BCLAF1 ZSWIM6 SLAIN1 ZBTB18	1.50e-04	198	113	5	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(6)_Endothelial-E\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.50e-04	198	113	5	a5e1b321376caf262ea48904d31afd1b8e9d3be2
ToppCell	Bronchial-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.53e-04	199	113	5	36a230b80096455df26c2e2c8c05fd6b231508c5
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	F8 PTPRB EFNB2 EEPD1 HYAL2	1.53e-04	199	113	5	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.53e-04	199	113	5	9735a1dc10910f02f1106b20ae5ab4c09c21305e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.53e-04	199	113	5	33f1669eeb701986b4dec409efdb6c06c3c41c2b
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Artery\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.57e-04	200	113	5	34b279804475ea58fbb052b96f44128c082627a9
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.57e-04	200	113	5	8552cc7a439449b30b59760c3e8667217b9852b5
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.57e-04	200	113	5	5ec31c1be6bcc4124e1489d136570f3de33cc2e9
ToppCell	Parenchyma_COVID-19-Endothelial-TX\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.57e-04	200	113	5	abcbd5a156aa4fd51d284441388975c81c0b88ae
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRB EFNB2 HMCN2 ADAMTS6 HYAL2	1.57e-04	200	113	5	93e13937ec74418a697c37d56f57509fb2154780
ToppCell	Lung_Parenchyma-Severe-Endothelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	F8 PTPRB EFNB2 ADAMTS6 HYAL2	1.57e-04	200	113	5	d9d0ffa18e5b4647966e19ad9830cbba6120677e
Computational	Genes in the cancer module 267.	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.58e-06	15	65	4	MODULE_267
Computational	Ion channels.	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.93e-05	27	65	4	MODULE_214
Computational	AcetylCholine receptors.	CHRNA2 CHRNB1 CHRNB3	7.33e-05	14	65	3	MODULE_328
Drug	perhydrohistrionicotoxin	CHRNA2 CHRNB1 CHRNB2 CHRNB3 SYMPK	2.77e-08	19	111	5	CID000107881
Drug	beta-erythroidine	CHRNA2 CHRNA5 CHRNB2	4.50e-07	4	111	3	ctd:C004873
Drug	(-)-pictamine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	7.01e-07	15	111	4	CID006918623
Drug	(-)-lepadin B	CHRNA2 CHRNB1 CHRNB2 CHRNB3	7.01e-07	15	111	4	CID006918624
Drug	UB-165	CHRNA2 CHRNB1 CHRNB2 CHRNB3	7.01e-07	15	111	4	CID004694339
Drug	AC1L2SVN	CHRNA2 CHRNB1 CHRNB2 CHRNB3	9.31e-07	16	111	4	CID000127922
Drug	ABT-594	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.55e-06	18	111	4	CID003075702
Drug	AC1LCVGE	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.55e-06	18	111	4	CID000656712
Drug	AC1L9P88	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-06	19	111	4	CID000450860
Drug	4-(N-maleimido)benzyltrimethylammonium	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-06	19	111	4	CID000162425
Drug	isoarecolone	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-06	19	111	4	CID000146970
Drug	beta-erythroidine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-06	19	111	4	CID000010074
Drug	decamethonium	CHRNA2 CHRNA5 CHRNB2	2.23e-06	6	111	3	ctd:C033019
Drug	3-(2-azetidinylmethoxy)pyridine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.44e-06	20	111	4	CID000001962
Drug	3H-diazirine	CHRNA2 CHRNB1 CHRNB2 CHRNB3 PARPBP	2.63e-06	45	111	5	CID000078958
Drug	philanthotoxin	CHRNA2 CHRNB1 CHRNB2 CHRNB3 SYMPK	2.63e-06	45	111	5	CID000115201
Drug	dinotefuran	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.00e-06	21	111	4	CID000197701
Drug	meproadifen	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.00e-06	21	111	4	CID000189752
Drug	AR-R17779	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.66e-06	22	111	4	CID005310971
Drug	histrionicotoxin	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.66e-06	22	111	4	CID005282247
Drug	clothianidin	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.66e-06	22	111	4	CID000213027
Drug	ethidium bromide	DBH AHDC1 CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.75e-06	85	111	6	CID000003624
Drug	neuroNal	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	4.04e-06	49	111	5	CID000010535
Drug	AC1L3BL8	CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.41e-06	23	111	4	CID000086457
Drug	alpha-conotoxin ImI	CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.41e-06	23	111	4	CID000133011
Drug	alpha-conotoxin SI	CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.41e-06	23	111	4	CID000163979
Drug	CID6325740	CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.41e-06	23	111	4	CID006325740
Drug	ABT-418	CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.41e-06	23	111	4	CID000119380
Drug	Skpymrfamide	CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.41e-06	23	111	4	CID000132661
Drug	McN-A-343	CHRNA2 CHRNB1 CHRNB2 CHRNB3 BRI3	4.47e-06	50	111	5	CID000004022
Drug	procyclidine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	5.27e-06	24	111	4	CID000004919
Drug	anabaseine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	5.27e-06	24	111	4	CID000018985
Drug	intruder	CHRNA2 CHRNB1 CHRNB2 CHRNB3	5.27e-06	24	111	4	CID000213021
Drug	tetramethylammonium	CHRNA2 CHRNB1 CHRNB2 CHRNB3 TNR	5.99e-06	53	111	5	CID000006380
Drug	Dimethylphenylpiperazinium Iodide	CHRNA2 CHRNA5 CHRNB2	6.20e-06	8	111	3	ctd:D004246
Drug	epibatidine	CHRNA2 CHRNA5 CHRNB2	6.20e-06	8	111	3	ctd:C082748
Drug	anabasine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	6.25e-06	25	111	4	CID000002181
Drug	varenicline	CHRNA2 CHRNB1 CHRNB2 CHRNB3	6.25e-06	25	111	4	CID000170361
Drug	pempidine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	6.25e-06	25	111	4	CID000006603
Drug	benzquinamide	CHRNA2 CHRNB1 CHRNB2 CHRNB3	7.36e-06	26	111	4	CID000002342
Drug	beta-eudesmol	CHRNA2 CHRNB1 CHRNB2 CHRNB3	7.36e-06	26	111	4	CID000091457
Drug	curarine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	7.36e-06	26	111	4	CID000198004
Drug	methylcarbamylcholine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	8.61e-06	27	111	4	CID000004136
Drug	nornicotine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	8.61e-06	27	111	4	CID000000412
Drug	pozanicline	CHRNA5 CHRNB1 CHRNB2	9.27e-06	9	111	3	ctd:C108326
Drug	bromoacetylcholine bromide	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.16e-05	29	111	4	CID000204966
Drug	otenzepad	CHRNA2 CHRNB1 CHRNB2 CHRNB3 BRI3	1.20e-05	61	111	5	CID000107867
Drug	tetrahydrodeoxycortisol	ELP1 CHRNA2 CHRNB1 CHRNB2	1.52e-05	31	111	4	CID000010593
Drug	AC1L1JK6	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.52e-05	31	111	4	CID000005077
Drug	tropicamide	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.73e-05	32	111	4	CID000005593
Drug	benzilate	CHRNA2 CHRNB1 CHRNB3 CACNA2D4 BRI3	1.77e-05	66	111	5	CID000201538
Drug	Dns-C6-Cho	CHRNA2 CHRNB1 CHRNB3	1.81e-05	11	111	3	CID000124728
Drug	AC1L9NC9	CHRNA2 CHRNB1 CHRNB3	1.81e-05	11	111	3	CID000449642
Drug	cytisine	CHRNA2 CHRNA5 CHRNB2	1.81e-05	11	111	3	ctd:C004712
Drug	dihydronereistoxin	CHRNA2 CHRNB1 CHRNB3	1.81e-05	11	111	3	CID000121232
Drug	LJP 1082	CHRNA2 CHRNB1 CHRNB3	1.81e-05	11	111	3	CID003037609
Drug	bipinnatin-B	CHRNA2 CHRNB1 CHRNB3	1.81e-05	11	111	3	CID000127363
Drug	methamidophos	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-05	33	111	4	CID000004096
Drug	decamethonium	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-05	33	111	4	CID000002968
Drug	cytisine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	1.96e-05	33	111	4	CID000010235
Drug	GTS-21	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.22e-05	34	111	4	CID005310985
Drug	l-Lobeline	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.22e-05	34	111	4	CID000003945
Drug	thiacloprid	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.22e-05	34	111	4	CID000115224
Drug	ND-186	TRIM39 DBH	2.36e-05	2	111	2	CID000173872
Drug	trifluoropentoxypicolinic acid	TRIM39 DBH	2.36e-05	2	111	2	CID000156082
Drug	AC1L9P8C	CHRNA2 CHRNB1 CHRNB3	2.40e-05	12	111	3	CID000450864
Drug	SureCN373116	CHRNA2 CHRNB1 CHRNB3	2.40e-05	12	111	3	CID010085732
Drug	(+/-)-Epibatidine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.49e-05	35	111	4	CID000001204
Drug	atracurium	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.49e-05	35	111	4	CID000047319
Drug	EPTC	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.49e-05	35	111	4	CID000012968
Drug	PhTX-343	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.79e-05	36	111	4	CID000159548
Drug	nereistoxin	CHRNA2 CHRNB1 CHRNB3	3.11e-05	13	111	3	CID000015401
Drug	1-acetyl-4-methylpiperazine methiodide	CHRNA2 CHRNB1 CHRNB3	3.11e-05	13	111	3	CID004392675
Drug	C-toxiferine-I	CHRNA2 CHRNB1 CHRNB3	3.11e-05	13	111	3	CID005089093
Drug	bipinnatin-A	CHRNA2 CHRNB1 CHRNB3	3.11e-05	13	111	3	CID000196603
Drug	bipinnatin-C	CHRNA2 CHRNB1 CHRNB3	3.11e-05	13	111	3	CID000129977
Drug	HHSiD	CHRNA2 CHRNB1 CHRNB3 BRI3	3.12e-05	37	111	4	CID000003602
Drug	O585	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.12e-05	37	111	4	CID000107646
Drug	NSC-293162	CHRNA2 CHRNB1 CHRNB2 CHRNB3	3.48e-05	38	111	4	CID000004675
Drug	AP-5	ZSWIM6 REPIN1 CHRNA2 CHRNB1 CHRNB3 CACNA2D4	3.92e-05	128	111	6	CID000001216
Drug	2,3-dichlorooctafluorobutane	CHRNA2 CHRNB1 CHRNB3	3.95e-05	14	111	3	CID000078982
Drug	LNF 209	CHRNA2 CHRNB1 CHRNB3	3.95e-05	14	111	3	CID000132666
Drug	AC1L1BQX	ELP1 CHRNA2 CHRNB1 CHRNB2 CHRNB3	4.25e-05	79	111	5	CID000001565
Drug	methylatropine	BCLAF1 CHRNA2 CHRNB1 CHRNB3	4.27e-05	40	111	4	CID000005860
Drug	bupropion	CHRNA2 CHRNA5 CHRNB1 CHRNB2 CHRNB3	4.80e-05	81	111	5	CID000000444
Drug	anatoxin-a hydrochloride	CHRNA2 CHRNB1 CHRNB3	4.92e-05	15	111	3	CID000135265
Drug	SAD-128	CHRNA2 CHRNB1 CHRNB3	4.92e-05	15	111	3	CID000162008
Drug	N-methylcytisine	CHRNA2 CHRNB1 CHRNB3	4.92e-05	15	111	3	CID000234566
Drug	aa373	CHRNA2 CHRNB1 CHRNB3	4.92e-05	15	111	3	CID000191672
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; HL60; HT_HG-U133A	MAZ DCLRE1B ZKSCAN5 NFIC ZFYVE26 PARPBP NOTCH2	5.02e-05	196	111	7	1312_DN
Drug	N-methylscopolamine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	5.19e-05	42	111	4	CID000004120
Drug	QX-222	CHRNA2 CHRNB1 CHRNB2 CHRNB3	5.19e-05	42	111	4	CID000005014
Drug	gallamin	CHRNA2 CHRNB1 CHRNB2 CHRNB3	5.70e-05	43	111	4	CID000067425
Drug	Hexamethonium	CHRNA2 CHRNA5 CHRNB2	6.03e-05	16	111	3	ctd:D018738
Drug	3-(trifluoromethyl)-3-(m-iodophenyl)diazirine	CHRNA2 CHRNB1 CHRNB3	6.03e-05	16	111	3	CID000123866
Drug	benzoquinonium	CHRNA2 CHRNB1 CHRNB3	6.03e-05	16	111	3	CID000009393
Drug	PNU-282,987	CHRNA2 CHRNB1 CHRNB3	6.03e-05	16	111	3	CID004655349
Drug	dihydro-beta-erythroidine	CHRNA2 CHRNB1 CHRNB2 CHRNB3	6.25e-05	44	111	4	CID000031762
Drug	sazetidine-A	CHRNA2 CHRNB2	7.04e-05	3	111	2	ctd:C514816
Drug	Nsc36388	CHRNA2 CHRNB1 CHRNB3	7.30e-05	17	111	3	CID000014954
Disease	congenital myasthenic syndrome (implicated_via_orthology)	CHRNA2 CHRNB1 CHRNB2 CHRNB3	2.77e-07	16	106	4	DOID:3635 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	DBH JMJD1C CHRNA2 CHRNB1 CHRNB2 CHRNB3 NOTCH2	6.93e-06	195	106	7	DOID:1574 (implicated_via_orthology)
Disease	smoking cessation	ZBTB20 MCM2 DBH JMJD1C CHRNA2 CHRNA5 CHRNB3 NLGN2	2.35e-05	325	106	8	EFO_0004319
Disease	Autosomal dominant nocturnal frontal lobe epilepsy	CHRNA2 CHRNB2	7.63e-05	4	106	2	cv:C3696898
Disease	neutrophil count	SCFD2 DCLRE1B ZMIZ1 PTGFRN ZKSCAN5 GLCCI1 JMJD1C CHRNB2 HIVEP3 CLK2 BEND7 ZNF398 BRI3 TNR NOTCH2	1.25e-04	1382	106	15	EFO_0004833
Disease	post-operative atrial fibrillation, response to surgery	ZBTB20 C13orf42	1.27e-04	5	106	2	EFO_0009951, EFO_0009952
Disease	nicotine dependence	DBH CHRNA5 CHRNB2 CHRNB3	1.83e-04	78	106	4	EFO_0003768
Disease	peptic ulcer disease	CERKL GGT1 JRK	2.27e-04	33	106	3	MONDO_0004247
Disease	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	CHRNA2 CHRNB2	2.65e-04	7	106	2	C3696898
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT2P GGT1	2.65e-04	7	106	2	DOID:5022 (biomarker_via_orthology)
Disease	alcohol dependence (biomarker_via_orthology)	GGT2P GGT1	3.53e-04	8	106	2	DOID:0050741 (biomarker_via_orthology)
Disease	Alcoholic Intoxication, Chronic	GOLM2 DBH ZNF699 CHRNA5 GGT1 CHRNB3	4.24e-04	268	106	6	C0001973
Disease	time to first cigarette measurement	CHRNA5 CHRNB3	4.53e-04	9	106	2	EFO_0010126
Disease	myeloid white cell count	SCFD2 ZKSCAN5 GLCCI1 JMJD1C HIVEP3 BEND7 ZNF398 BRI3 TNR NOTCH2 PARP12	5.58e-04	937	106	11	EFO_0007988
Disease	esophagus squamous cell carcinoma (is_implicated_in)	CHRNA5 FAT1 EFNB2	5.73e-04	45	106	3	DOID:3748 (is_implicated_in)
Disease	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	CHRNA5 CHRNB3	8.24e-04	12	106	2	C1861063
Disease	autism spectrum disorder (implicated_via_orthology)	ABCA3 CHRNB2 TAOK2 NLGN2	2.24e-03	152	106	4	DOID:0060041 (implicated_via_orthology)
Disease	esophagus squamous cell carcinoma (is_marker_for)	CHRNA5 FAT1 EFNB2	2.43e-03	74	106	3	DOID:3748 (is_marker_for)
Disease	gastric ulcer	GGT1 JRK	2.57e-03	21	106	2	EFO_0009454
Disease	colorectal carcinoma (is_implicated_in)	PTPRB EFNB2	2.82e-03	22	106	2	DOID:0080199 (is_implicated_in)
Disease	triacylglycerol 54:8 measurement	CACNA2D4 FCMR	3.08e-03	23	106	2	EFO_0010426
Disease	tobacco smoke exposure measurement	DBH CHRNB3	3.35e-03	24	106	2	EFO_0009115

Protein segments in the cluster

Peptide	Gene	Start	Entry
EITGTHHHTRLIFVF	nan	26	Q8N976
TQTSHLPESERIHHT	ACIN1	751	Q9UKV3
FVINVHHRSSSTYHP	CHRNB3	316	Q05901
YLHHTINLTHSLPAA	nan	41	Q9N2J8
THHPRVYNIHSRTVT	BRI3	51	O95415
EHHSTIVSTRHYRAP	CLK2	336	P49760
HVQAPFTSATHLEHV	ARFGEF1	931	Q9Y6D6
PHHTSLVVYHVAVTL	GPR20	271	Q99678
HQTHQTSLQYRHPTS	CCNJ	281	Q5T5M9
PRRHSEDIAAHTVHT	C13orf42	206	A0A1B0GVH6
TVFVLNVHHRSPSTH	CHRNA2	346	Q15822
LVHHHVPNATLESSA	ABCA3	776	Q99758
SVVVLNLHHRSPHTH	CHRNB1	326	P11230
RQSPLHGNHITISHT	GLCCI1	256	Q86VQ1
VHQAPDTQSISHFLH	AHDC1	646	Q5TGY3
LQSVHHPESRSSIQH	CLSTN2	811	Q9H4D0
SPITAHLLHRHLQVS	DCLRE1B	51	Q9H816
HSVLPLLLTTSHHNA	DMXL1	646	Q9Y485
FHHLIPAHTFTNIST	EEPD1	466	Q7L9B9
VHPSHHDTAVLITRE	ADAMTS20	346	P59510
TVSYSLPINNTHIHH	ADAMTS6	226	Q9UKP5
TISPNSHFHVATHNR	PCDHB5	171	Q9Y5E4
NTIHHHGTSILTLFR	PARPBP	381	Q9NWS1
ARFVVGSHVRHHPSN	MCM2	676	P49736
THSTARLSFVTPRHH	FAT1	3761	Q14517
TVLPSVSQLLSHHHI	NOTCH2	2216	Q04721
VSQLLSHHHIVSPGS	NOTCH2	2221	Q04721
SQTIPKHVFEHTFHR	PTPRB	951	P23467
THHANHALPVYVFTR	HYAL2	281	Q12891
SHAPTGSSVHNILHI	LIPN	281	Q5VXI9
AILHSSPESASHQLH	LZTS1	136	Q9Y250
PLHVQSHLYSHLSSI	M1AP	441	Q8TC57
HAAAYTTHPSTLVHQ	HIPK1	1141	Q86Z02
RHQVPRAEISHHISS	GTSF1	56	Q8WW33
RIHPTATHHITNEGV	HMCN2	976	Q8NDA2
RSHSITIDFTHPCHV	KATNIP	1056	O60303
LHPHRQRHFITSSSS	LRRC53	516	A6NM62
HLPHQIASHSVTTFR	JMJD1C	1166	Q15652
HRKHSPQHTTTLSLS	EFNB2	256	P52799
ASQPTSTIILHSHHL	ERAP1	86	Q9NZ08
FHHIFVPSVREHFRT	JRK	271	O75564
HLNSHVRQVHSTERP	MAZ	351	P56270
TARPSQFPHSLHLHS	TUBGCP5	226	Q96RT8
AVSHSEFSPRSVIHH	ELP1	516	O95163
NIHSIHFSGHVFTVR	F8	1971	P00451
HSLTTEHNLSVLRTH	PARP12	116	Q9H0J9
ISPNSHFHILTRNHS	PCDHB4	171	Q9Y5E5
LHPAPTSLSHTFHRA	FRMD1	496	Q8N878
TVFAINIHHRSSSTH	CHRNA5	331	P30532
FIHNPHTRNQHVSAS	BBS2	41	Q9BXC9
HLIHFVQVQPSHTRT	C3orf84	126	H3BNL1
HHHSAAQPLVSPISA	CACNA2D4	946	Q7Z3S7
TSESFIQHIVSLVHH	BCLAF1	601	Q9NYF8
HILHPTHSQALAVLS	CDON	221	Q4KMG0
PSGIHIFASQLHTHL	DBH	401	P09172
THQPVAIHPSSVLFH	DHX33	646	Q9H6R0
STNVLAHSLHGVPHV	CERKL	301	Q49MI3
HSFLITQVSATLHHQ	BEND7	481	Q8N7W2
RHFSNHATHVEFLPV	DDHD1	441	Q8NEL9
PHLHNLHTELFTTTT	NLGN2	606	Q8NFZ4
ALETRHHHTQIASTF	GGT2P	526	P36268
NQTSVSHFILVGLHH	OR10G6	26	Q8NH81
DHAHHVKFSSSVPQR	NRK	796	Q7Z2Y5
RDSLVHSSPHVALSH	PTGFRN	336	Q9P2B2
HSSPHVALSHVDARS	PTGFRN	341	Q9P2B2
VSQHESHQAISHLPT	GOLM2	276	Q6P4E1
HAHVNSRISVHSPLD	RTTN	341	Q86VV8
QSPALHRAAAHIHSS	SZT2	1716	Q5T011
QPHHEGRSLSHIFTF	SPATA48	196	A4D263
HTHDVRTVAHSPTAL	UTP4	286	Q969X6
ISHTHRAHTVVPLDD	TRIM39	131	Q9HCM9
NPVHSHIGATVSHQT	RESF1	126	Q9HCM1
IAQHSHSPHCTVSIV	PKDREJ	1066	Q9NTG1
LQHRVHSVGHFPVSI	SLAIN1	456	Q8ND83
SSAHVALQVHPHCTV	SHARPIN	236	Q9H0F6
EHTVTSHSSIIHRLP	TAOK2	406	Q9UL54
SLHSESLHPTVFVQH	SPATA31D4	506	Q6ZUB0
TVSHAVHLTANHVPA	SCFD2	106	Q8WU76
LSSFTQHHRPVIAVH	NFIC	346	P08651
HQGFQHLVHSLTVPS	SERPINA9	111	Q86WD7
THLVAHSRVHSGERP	REPIN1	416	Q9BWE0
VCVLNVHHRSPTTHT	CHRNB2	316	P17787
SFSNTSHLIIHERTH	ZNF572	196	Q7Z3I7
SLHSESLHPTVFVQH	SPATA31D3	506	P0C874
NTTHSRLTHISPRHY	ZSWIM5	1121	Q9P217
PVFQHHTSHTVRQSR	ZNF565	186	Q8N9K5
ITTIHHTFLQHFAVS	ZNF804B	1206	A4D1E1
FHSLSSFQVHERIHT	ZNF136	261	P52737
FHSLSPFRIHERTHT	ZNF136	401	P52737
SATLAVHHRTHLEPA	ZNF691	211	Q5VV52
VFNHPSTLRSHVSIH	ZNF177	156	Q13360
FHTSYHSQAVHIRPV	PIGT	211	Q969N2
AFHSQISSHATSHPV	RNF111	691	Q6ZNA4
SLLSQFSHHHVVVFL	SLC37A3	11	Q8NCC5
ADHRVHQVTPQTHFI	PITHD1	196	Q9GZP4
RSHHSISSQTFEHPL	RLIM	241	Q9NVW2
TFTHPSRLTYHLRVH	ZNF398	406	Q8TD17
SPHILQIHLSTHFRE	ZBTB18	381	Q99592
HLVTHQRTHTGERPF	ZNF774	361	Q6NX45
HTGVIPTHHQFITNE	SORBS1	761	Q9BX66
HHSSPTTQITHRPRV	FCMR	176	O60667
PISHLHFSHVTSSSV	TNR	776	Q92752
EALSHSSHVFTSHPR	HIVEP3	571	Q5T1R4
IFSHLPLHSQHLTRA	HIVEP3	2176	Q5T1R4
QTSHERPTDVAHSHL	TANGO6	781	Q9C0B7
LAHVRSFTPHQQAHI	SYMPK	1076	Q92797
PALIHSTHSLTNSHA	ZBTB20	46	Q9HC78
SSSAHPFISNLHTRH	ZNF839	106	A8K0R7
NTTHSRLTHISPRHY	ZSWIM6	1151	Q9HCJ5
VEHLVSHHSPQRTES	ZNF362	396	Q5T0B9
FSHPSDLVRHQRIHT	ZNF212	436	Q9UDV6
FSQSSHLVPHQRIHT	ZNF594	276	Q96JF6
TFSRSTHLIEHQGIH	ZNF883	161	P0CG24
AFISSSHLTVHIRTH	ZNF699	511	Q32M78
KFRSSTQLHELTPHH	SMC5	976	Q8IY18
TFSLPSLFHRHERTH	ZNF433	486	Q8N7K0
SHSVLYTLHHLTNLP	ZFYVE26	441	Q68DK2
FCLQTSLTLHHRIHP	ZNF850	151	A8MQ14
FRVSSHLVQHHSVHS	ZKSCAN5	411	Q9Y2L8
HNLAVSNHVFHLRPT	ZMIZ1	581	Q9ULJ6
SNHVFHLRPTVHQTL	ZMIZ1	586	Q9ULJ6
ALETRHHHTQIASTF	GGT1	526	P19440